Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Nozza

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Ebiomedicine|August 23, 2024
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
The New Microbiologica|October 3, 2022
The challenge of infectious diseases consultations in the emergency department: an Italian nationwide surveyNiccolò Riccardi, Roberta Maria Antonello, Andrea Giacomelli, et al.
Scientific Reports|February 18, 2017
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 controlMauro S Malnati, Elisabetta Ugolotti, Maria Cristina Monti, et al.
The Lancet. Infectious Diseases|September 7, 2023
Mpox in people with past infection or a complete vaccination course: a global case seriesAniruddha Hazra, Jason Zucker, Elizabeth Bell, et al.
Journal of Immunological Methods|October 4, 2011
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responsesMauro S Malnati, Silvia Heltai, Antonio Cosma, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)Cristina Mussini, Marco Falcone, Silvia Nozza, et al.
Frontiers in Immunology|March 1, 2019
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up StudyCecilia Sgadari, Paolo Monini, Antonella Tripiciano, et al.
Ebiomedicine|April 11, 2021
Anti-Tat immunity defines CD4<sup>+</sup> T-cell dynamics in people living with HIV on long-term cARTAntonella Tripiciano, Orietta Picconi, Sonia Moretti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 18, 2026
Implementation of HIV Pre-exposure Prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE Cohort SurveySilvia Nozza, Thomas Masoero, Alessandro Tavelli, et al.
Sexually Transmitted Infections|April 21, 2022
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in ItalyGiorgio Bozzi, Lavinia Fabeni, Isabella Abbate, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Ebiomedicine|August 23, 2024
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
The New Microbiologica|October 3, 2022
The challenge of infectious diseases consultations in the emergency department: an Italian nationwide surveyNiccolò Riccardi, Roberta Maria Antonello, Andrea Giacomelli, et al.
Scientific Reports|February 18, 2017
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 controlMauro S Malnati, Elisabetta Ugolotti, Maria Cristina Monti, et al.
The Lancet. Infectious Diseases|September 7, 2023
Mpox in people with past infection or a complete vaccination course: a global case seriesAniruddha Hazra, Jason Zucker, Elizabeth Bell, et al.
Journal of Immunological Methods|October 4, 2011
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responsesMauro S Malnati, Silvia Heltai, Antonio Cosma, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)Cristina Mussini, Marco Falcone, Silvia Nozza, et al.
Frontiers in Immunology|March 1, 2019
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up StudyCecilia Sgadari, Paolo Monini, Antonella Tripiciano, et al.
Ebiomedicine|April 11, 2021
Anti-Tat immunity defines CD4<sup>+</sup> T-cell dynamics in people living with HIV on long-term cARTAntonella Tripiciano, Orietta Picconi, Sonia Moretti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 18, 2026
Implementation of HIV Pre-exposure Prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE Cohort SurveySilvia Nozza, Thomas Masoero, Alessandro Tavelli, et al.
Sexually Transmitted Infections|April 21, 2022
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in ItalyGiorgio Bozzi, Lavinia Fabeni, Isabella Abbate, et al.
Pageof 18